Methimazole Dosage for 28-Week Pregnant Woman with Graves Disease
At 28 weeks gestation (second trimester), methimazole should be initiated at 5-10 mg daily and titrated to maintain maternal free T4 at or slightly above the upper limit of the non-pregnant reference range, using the lowest possible dose to avoid fetal hypothyroidism. 1
Drug Selection in Second/Third Trimester
Since this patient is at 28 weeks (well into the second trimester), methimazole is the preferred antithyroid drug over propylthiouracil (PTU). 2 The guidelines clearly state that PTU should only be used in the first trimester due to teratogenic concerns with methimazole during organogenesis, but after the first trimester, methimazole becomes preferred due to PTU's risk of potentially fatal hepatotoxicity. 2, 1
Specific Dosing Strategy
Initial Dose
- Start with 5-10 mg methimazole daily 1
- This is lower than non-pregnant dosing because pregnancy requires the minimal effective dose
Dose Adjustment Principles
The critical principle is the "adapted-dose strategy" - use the lowest possible dose that maintains:
- Free T4 at or slightly above the upper limit of the non-pregnant reference range 2
- TSH may remain suppressed throughout pregnancy and should NOT be used as the sole guide 2
- Total T4 and T3 slightly above normal pregnancy ranges if using those parameters 2
Important Caveat
Block-and-replace therapy (antithyroid drug plus levothyroxine) is contraindicated in pregnancy 2 because it requires higher doses of methimazole and increases risk of fetal hypothyroidism. One case report demonstrated gastroschisis with high-dose methimazole (120 mg/day) combined with block-and-replace therapy. 3
Monitoring Protocol
Thyroid function must be assessed every 2-4 weeks initially, then monthly once stable 1:
- Check free T4 and TSH every 2 weeks after initiation
- Once stable, monitor every 2-4 weeks throughout pregnancy
- Adjust dose based primarily on free T4 levels
Critical Safety Considerations
Fetal Risk
Even with maternal euthyroidism on antithyroid drugs, there remains risk of fetal hypothyroidism in the second and third trimesters when the fetal thyroid is functioning. 2 This is why the dose must be kept as low as possible while maintaining maternal thyroid hormone levels slightly elevated.
Dose Reduction Strategy
As pregnancy progresses, many women experience improvement in hyperthyroidism due to immune modulation. If maternal free T4 decreases on two successive assays at minimum antithyroid dose, consider discontinuing treatment. 1
Conversion from PTU
If this patient was previously on PTU in the first trimester, the conversion ratio is approximately 20-30:1 (PTU:methimazole). For example, 300 mg PTU ≈ 10-15 mg methimazole. 2 However, switching requires intensified monitoring as it can destabilize thyroid control. 1
Postpartum Planning
This patient will need close monitoring postpartum as relapse risk is high (up to 40% of cases). 1 TSH should be checked at 1,3, and 6 months after delivery. 1